Deutsche Bank Downgrades ResMed (RMD) to Hold
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $188.45 -0.1%
Rating Summary:
13 Buy, 10 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
13 Buy, 10 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Deutsche Bank downgraded ResMed (NYSE: RMD) from Buy to Hold.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $117.69 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- This digital health stock is ready to re-rate higher: Goldman
- Morgan Stanley Downgrades Cleveland-Cliffs (CLF) to Equalweight
- Canaccord Downgrades Apogee Therapeutics Inc (APGE) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Deutsche BankSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
